drugset / Trial / NCT04837807

Digital Device Users Who Are Treated With Systane Hydration PF

NCT04837807 ↗

RandomizedCrossoverSingle-blindTreatment

Summary

Systane Hydration PF is a recently released preservative-free artificial tear that is able to supplement the ocular surface's moisture while simultaneously soothing the eye. While Systane Hydration PF should in theory improve the symptoms and subsequently the quality of life of patients who have DES, this clinical application has yet to be tested. This drop furthermore is available in both unit-dose and multi-dose options; however, it is unclear if patient perceive a difference between the two dispensing methods. Therefore, the primary purpose of this study is to recruit patients who have DES and to treat them with Systane Hydration PF and determine how regular use of this drop impacts a patient's ocular surface symptoms and overall quality of life. This study will secondarily compare the two dispensing methods to determine if patients prefer one method over the other.

Timeline

Start
2021-08-18
Primary completion
2021-11-19
Completion
2021-11-19

Drugs

EvaluationDrugModalityDoseRoute
Subject Systane Hydration PF Unknown — Topical

Indications